157 related articles for article (PubMed ID: 15462486)
1. Analysis of molecular heterogeneity of prolactin in human systemic lupus erythematosus.
García M; Colombani-Vidal ME; Zylbersztein CC; Testi A; Marcos J; Arturi A; Babini J; Scaglia HE
Lupus; 2004; 13(8):575-83. PubMed ID: 15462486
[TBL] [Abstract][Full Text] [Related]
2. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
[TBL] [Abstract][Full Text] [Related]
3. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
[TBL] [Abstract][Full Text] [Related]
4. Hyperprolactinemia in males with systemic lupus erythematosus.
Mok CC; Lau CS; Lee KW; Wong RW
J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
[TBL] [Abstract][Full Text] [Related]
5. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
Leaños-Miranda A; Cárdenas-Mondragón G
Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
[TBL] [Abstract][Full Text] [Related]
6. [Importance of prolactin isoforms on ovary function in hyperprolactinemic women].
Romero C; León J; Jara R; González O
Rev Chil Obstet Ginecol; 1993; 58(6):465-9. PubMed ID: 7991872
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Goffin V; Leaños-Miranda A
J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
[TBL] [Abstract][Full Text] [Related]
8. [Antibodies against prolactin in patients with systemic lupus erythematosus and hyperprolactinemia].
Leaños Miranda L; Bustos López HH; Fraga Mouret A; Blanco Favela F; Dalila Pascoe Lira ME; Dalila Pascoe Lira C
Ginecol Obstet Mex; 1998 May; 66():179-86. PubMed ID: 9646575
[TBL] [Abstract][Full Text] [Related]
9. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.
Hattori N
J Clin Endocrinol Metab; 1996 Feb; 81(2):586-90. PubMed ID: 8636272
[TBL] [Abstract][Full Text] [Related]
10. Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus.
Blanco-Favela F; Chavez-Rueda K; Leaños-Miranda A
Lupus; 2001; 10(10):757-61. PubMed ID: 11721703
[TBL] [Abstract][Full Text] [Related]
11. Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
J Clin Endocrinol Metab; 2001 Jun; 86(6):2619-24. PubMed ID: 11397862
[TBL] [Abstract][Full Text] [Related]
12. Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia.
Paraiba DB; Soares CR; Bartolini P; Arthuso FS; Borba EF; Bonfa E; Bronstein MD
Clin Exp Rheumatol; 2010; 28(6):866-72. PubMed ID: 21205462
[TBL] [Abstract][Full Text] [Related]
13. Characterization of big, big prolactin in patients with hyperprolactinaemia.
Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
[TBL] [Abstract][Full Text] [Related]
14. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia.
Leaños A; Pascoe D; Fraga A; Blanco-Favela F
Lupus; 1998; 7(6):398-403. PubMed ID: 9736323
[TBL] [Abstract][Full Text] [Related]
15. Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
Lupus; 2001; 10(5):340-5. PubMed ID: 11403264
[TBL] [Abstract][Full Text] [Related]
16. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.
Cavaco B; Leite V; Santos MA; Arranhado E; Sobrinho LG
J Clin Endocrinol Metab; 1995 Aug; 80(8):2342-6. PubMed ID: 7629227
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia in asymptomatic patients is related to high molecular weight posttranslational variants or glycosylated forms.
Guitelman M; Colombani-Vidal ME; Zylbersztein CC; Fiszlejder L; Zeller M; Levalle O; Scaglia HE
Pituitary; 2002; 5(4):255-60. PubMed ID: 14558674
[TBL] [Abstract][Full Text] [Related]
18. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
[TBL] [Abstract][Full Text] [Related]
19. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
Buskila D; Lorber M; Neumann L; Flusser D; Shoenfeld Y
J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116
[TBL] [Abstract][Full Text] [Related]
20. Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations.
El-Garf A; Salah S; Shaarawy M; Zaki S; Anwer S
J Rheumatol; 1996 Feb; 23(2):374-7. PubMed ID: 8882050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]